Stocks and Investing
Stocks and Investing
Tue, November 24, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, November 23, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Yigal Nochomovitz Maintained (APLS) at Strong Buy with Increased Target to $67 on, Nov 23rd, 2020
Yigal Nochomovitz of Citigroup, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $53 to $67 on, Nov 23rd, 2020.
Yigal has made no other calls on APLS in the last 4 months.
There are 2 other peers that have a rating on APLS. Out of the 2 peers that are also analyzing APLS, 0 agree with Yigal's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Yigal
- Joseph Stringer of "Needham" Initiated at Strong Buy and Held Target at $59 on, Thursday, November 19th, 2020
- Derek Archila of "Stifel" Initiated at Strong Buy and Held Target at $40 on, Tuesday, September 1st, 2020
Contributing Sources